Jag Dosanjh

Jag Dosanjh is Senior Vice President, AbbVie and President, Immunology. In this role, he is responsible for leading the U.S. commercial business and global strategy across Immunology including dermatology, gastroenterology and rheumatology therapeutic areas from pipeline to commercialization.

Mr. Dosanjh joined AbbVie (Allergan) in 2011 and served in a variety of executive roles across Global Strategic Marketing, Market Access and Government Affairs and most recently served as President of the Neuroscience and Eye Care portfolios.

Prior to joining AbbVie, Mr. Dosanjh worked at GlaxoSmithKline in several executive positions in both Europe and United States with key areas of focus being Vaccine Biologicals, Diabetes, Respiratory and Commercial Operations. He is also a recipient of the Honorable Mentor award from the Healthcare Businesswomen’s Association.

Mr. Dosanjh holds a bachelor’s degree in business studies from Sheffield Hallam University in the United Kingdom.